Podcasts about Clinical pharmacy

Your primary care provider is doing their best. But there's something they may not be telling you — not because they're hiding it, but because they simply can't know everything.In this episode of Your Health University, Jamie Preston sits down with Scott Middleton — Founder and Chief Disruption Officer of Your Health — to talk about one of the most underutilized parts of the American healthcare system: specialty care. Scott shares real stories from the field that will make you rethink what you expect from your next appointment, including a patient who had been living in a nursing home for years without ever being offered a weight-loss medication that was available to her, and a lawsuit that turned on a single chest x-ray that no one thought to order.What you'll learn in this episode:Why your primary care provider legally cannot keep up with every new medication, treatment, and specialist recommendation — and what to do about itWhat GLP-1 medications are, who qualifies, and why so many eligible patients are never told they existThe standard of care around lung cancer screening for smokers — and why not knowing this can have life-altering consequencesHow to ask for a specialist referral (and what happens if your provider pushes back)Why behavioral health is one of the most under-accessed specialties in America — and how to change that for yourselfWhat "integrated care" actually looks like when it works — and what you deserve to expect from your healthcare teamYou are the CEO of your own health. This episode gives you tools to act like it. www.YourHealth.Org

Do you have clients who react to everything? What if their symptoms, scattered as they seem, share one cause? In this episode of IRH Clinician's Corner, Margaret Floyd Barry talks with Dr. Meg Mill about mast cell activation syndrome (MCAS) and histamine intolerance, two conditions that trip up even practitioners with years of clinical experience. Dr. Mill walks through the clinical signs to watch for and makes the case for slowing down and sequencing your approach with these clients. In this episode: The difference between histamine intolerance and MCAS Symptoms that point to histamine issues but rarely get connected to them Why perimenopause can trigger new histamine symptoms How gut health and histamine-producing bacteria factor in Why common gut-healing protocols can backfire with these clients Why nervous system regulation is central to resolving these cases The Clinician's Corner is brought to you by the Institute of Restorative Health: https://instituteofrestorativehealth.com/ Upcoming Event: Margaret Floyd Barry is teaching a free session on September 15 for practitioners who want a smaller, structured offer to bring new clients in the door. She's walking through how to build a challenge-style entry point using CGM data, tested across real client volume in our own corporate wellness practice. If you've been asking too much, too soon, of new clients before they know you, this is worth an hour. Register Here! Follow us on IG: https://www.instagram.com/instituteofrestorativehealth/ Join our email list here: https://instituteofrestorativehealth.com/join-our-email-list/ Book a call with the admissions team to continue your training: https://instituteofrestorativehealth.com/study-with-us/?utm_source=email Connect with Dr. Meg Mill: Website: http://www.megmill.com Instagram: https://www.instagram.com/drmegmill/ Get Dr. Meg's FREE guide on MCAS: https://go.megmill.com/mcas And her FREE guide on Histamine Intolerance: https://go.megmill.com/histamine Timestamps:  00:00 Upcoming glucose monitor challenge 09:21 Understanding overactive mast cells 13:51 Understanding immune system triggers 18:14 Addressing severe food reactions 26:13 Understanding histamine intolerance in patients 31:30 Identifying histamine intolerance symptoms 34:35 Microdosing supplements for healing 40:14 Balancing hormones and detox pathways 47:05 Focusing on cell and hormone health 52:24 Importance of setting client expectations 54:13 Challenges with rigid health protocols 01:02:02 Guides on histamine intolerance and mast cell activation Guest bio:  Dr. Meg Mill is a leading women's health expert, Doctor of Clinical Pharmacy, and Certified Functional Medicine Practitioner with over two decades of clinical experience. She helps women around the world resolve chronic symptoms like fatigue, digestive issues, migraines, hormonal imbalances, and histamine-related conditions—especially when conventional medicine has failed to connect the dots. She empowers women to rebalance their bodies, regulate their nervous systems, and reclaim their energy, clarity, and confidence. Through her virtual Functional Medicine practice, Dr. Meg has guided hundreds of women to lasting relief and transformation worldwide. A bestselling author and host of the top-rated podcast A Little Bit Healthier, she's also a sought-after speaker and summit host. Her work has been featured on Fox News, CNN, ABC, NBC, CBS, and in Forbes Health, Reader's Digest, Health Magazine and Mind Body Green.  Keywords: functional health, MCAS, mast cell activation syndrome, histamine intolerance, histamine symptoms, continuous glucose monitor, CGM challenge, diamine oxidase, methylation, nervous system regulation, gut health, stool testing, histamine-producing bacteria, perimenopause, estrogen-progesterone balance, mold toxicity, immune system, detox pathways, methylation support, B vitamins, thiamine, glutathione, adrenals, hormone imbalances, thyroid health, autoimmune disease, SIBO, probiotics, low histamine diet, mast cell stabilizers, food sensitivities Disclaimer: The views expressed in the IRH Clinician's Corner series are those of the individual speakers and interviewees, and do not necessarily reflect the views of the Institute of Restorative Health, LLC. The Institute of Restorative Health, LLC does not specifically endorse or approve of any of the information or opinions expressed in the IRH Clinician's Corner series. The information and opinions expressed in the IRH Clinician's Corner series are for educational purposes only and should not be construed as medical advice. If you have any medical concerns, please consult with a qualified healthcare professional. The Institute of Restorative Health, LLC is not liable for any damages or injuries that may result from the use of the information or opinions expressed in the IRH Clinician's Corner series. By viewing or listening to this information, you agree to hold the Institute of Restorative Health, LLC harmless from any and all claims, demands, and causes of action arising out of or in connection with your participation. Thank you for your understanding.  

In this episode of The Dish on Health IT, Tony Schueth, CEO of Point-of-Care Partners (POCP), welcomes Angel Ballew, Head of Pharmacy Clinical Programs & Services at Centene Corporation, along with Seth Joseph, Managing Director of Summit Health Advisors, and Jason Reed, Senior Consultant at Point-of-Care Partners, for a discussion about what it will take to scale pharmacist-delivered clinical services. The conversation builds on findings from the NCPDP Foundation-funded white paper, A Business Model Framework to Scale Pharmacy-Delivered Clinical Services, developed with contributions from Point-of-Care Partners and Summit Health Advisors. The research starts from an important premise: there is already significant evidence that pharmacist-delivered clinical services can improve patient outcomes. The harder question is how to make those services operationally and financially sustainable at scale. Tony begins by asking Angel about the role pharmacists can play in closing care gaps, particularly for vulnerable and rural populations. Angel notes that Centene serves approximately 3.5 million people living in rural communities, but emphasizes that access challenges extend beyond geography to transportation, housing, food insecurity, and other social determinants of health. Against that backdrop, pharmacists can be among the most accessible healthcare professionals in a community and may interact with patients more frequently than physicians or other providers. Angel describes opportunities for pharmacists to reinforce medication adherence, identify medication-related concerns, provide immunizations, support test-and-treat services, conduct screenings, and perform other clinical services. As states continue expanding pharmacists' scope of practice and provider recognition, she sees opportunities to further integrate pharmacists into the healthcare team, particularly in communities with limited provider access. Seth and Jason broaden the discussion by sharing what emerged from the stakeholder interviews and industry research behind the white paper. Pharmacist-delivered services are already being piloted or implemented across areas including gaps-in-care counseling, test-and-treat programs, medication counseling and medication therapy management, immunizations and preventive screenings, and chronic disease management. Jason notes that pharmacists can play an important role between physician visits for patients managing conditions such as diabetes and hypertension. The conversation then turns to one of the biggest obstacles to scale: reimbursement and credentialing. Angel describes the tension between generating enough patient volume to make participation worthwhile for pharmacies and demonstrating enough outcomes and value to justify health plan investment. She discusses Centene's work to make credentialing requirements clearer for pharmacy partners, including the internal education required to bring pharmacy into processes traditionally designed around other healthcare providers. Tony asks Seth what the research suggests needs to change. Seth explains that the findings pointed strongly toward health plans and pharmacies working together to lead the development of sustainable models. Pharmacy benefit managers remain important participants with established relationships, networks, technology, and processes, but Seth describes the difficulty an innovative program champion within a PBM can face when they must first secure a client and then assemble participating pharmacies. Health plans may have greater ability to initiate programs and bring the necessary parties together, although their different lines of business and geographic markets add their own complexity. Angel shares how some of this has played out at Centene. The organization has worked directly with pharmacy communities and industry partners, often state by state because of differences in pharmacist scope-of-practice requirements. At the same time, Centene has developed a national program with consistent quality measures and an infrastructure that can support additional pharmacy service opportunities. That experience provides a real-world look at what scaling can require. Angel describes participation approaching 73 percent nationally and nearly 30,000 pharmacies contracted to participate in the program, including growth of more than 10,000 pharmacies over the past several years. She points to consistency as an important part of building participation. Rather than continually replacing programs with something new, Centene has gathered feedback and iterated, helping pharmacy partners gain confidence that the opportunity is stable enough to warrant their investment. The discussion then returns to a central finding of the white paper: the “cold start,” or chicken-and-egg, problem. Pharmacies may hesitate to invest in technology, staffing, workflow redesign, and clinical capabilities until sufficient patient volume exists, while health plans want sufficient pharmacy participation before investing in programs and measuring outcomes. Meanwhile, differences in credentialing, enrollment, reimbursement, contracting, and reporting continue to create practical barriers. Tony introduces the concept of regional Pharmacy Health Alliances for Reimbursable Medical Services, or PHARMS, as one potential approach to addressing the cold-start problem by bringing health plans and pharmacies together within a geographic market. Angel agrees that the concept begins with the right problem. The industry does not lack evidence that pharmacists can improve outcomes or help address gaps created by provider shortages. What remains less aligned is the business model. She cautions, however, that health plan operations vary considerably across lines of business, patient populations, benefit designs, quality priorities, and state Medicaid requirements. A regional model therefore needs enough flexibility to account for those differences. Seth explains that this variation is precisely why the research pointed toward regional collaboration rather than attempting to solve every issue nationally at once. The goal is not necessarily complete standardization, but identifying enough commonality among health plans and lines of business to prioritize a smaller number of services and begin building the infrastructure needed to support them. Angel views those complexities as design considerations rather than reasons not to pursue regional collaboration. She also sees the potential for lessons and common approaches developed regionally to eventually contribute to greater standardization nationally, particularly within individual product lines. Jason brings the discussion back to the pharmacy perspective. Pharmacies need confidence that services will be reimbursed before they can reasonably invest in technology, redesign workflows, train staff, and begin documenting clinical care differently. Regional collaboration among multiple payers could give pharmacies greater confidence that those investments will support sufficient patient volume while creating value for patients, pharmacies, and payers. From there, the conversation moves to another critical requirement for advanced pharmacy practice: data interoperability. Tony points out that pharmacists cannot effectively close care gaps if relevant clinical information remains siloed. Angel agrees that pharmacists need timely, actionable clinical information and enough context beyond the dispensing system to intervene effectively. At the same time, she cautions against overwhelming pharmacists with more information than they can realistically use within their workflows. She also challenges the idea that interoperability must be an all-or-nothing proposition. While the industry continues working toward a more ideal interoperability environment, imperfect data exchange should not prevent health plans and pharmacies from making progress today. Jason expands on the interoperability challenge by discussing the emerging concept of a pharmacy EHR. Pharmacy management systems are highly effective at supporting medication dispensing and claims transactions, but advanced clinical services require additional information. He argues that the answer is not simply to deliver the entire EHR to the pharmacist. Instead, the industry needs to identify the minimum actionable clinical information pharmacists need to make better decisions and perform specific services. Just as importantly, Jason emphasizes that pharmacy interoperability must be bidirectional. Pharmacists increasingly generate clinically valuable information through patient interactions, and that information also needs to reach providers and other members of the care team. Angel notes that Centene already receives some information back from pharmacies, including through programs involving social determinants of health, although the more seamless bidirectional infrastructure envisioned by the group is still developing. Looking ahead five years, Seth describes himself as a “data-driven optimist.” He points to momentum across private-sector organizations, national and independent pharmacies, state governments, and policy initiatives. While significant reimbursement, policy, and infrastructure challenges remain, he believes many of the pieces needed to overcome the cold-start problem are beginning to come together. Angel shares that optimism. Her hope is that pharmacists become a much more integrated and visible part of frontline healthcare delivery. The COVID-19 pandemic demonstrated how accessible and valuable pharmacists can be when the healthcare system needs them, and she sees an opportunity to continue moving the profession beyond its traditional dispensing role. Jason adds that demographic pressures, including an aging population and primary care capacity challenges, will continue creating demand for pharmacists to practice at the top of their licenses. He expects states to continue expanding pharmacist prescribing authority and clinical roles while technology, interoperability, and potentially AI help pharmacies operate more efficiently and support broader clinical services. Tony closes with the question asked of every guest on The Dish on Health IT: what is one habit or perception healthcare stakeholders should change or revisit starting tomorrow? Angel challenges listeners to think about pharmacists as more than medication experts. They are also access experts. In a healthcare system facing provider shortages, increasing complexity, barriers to care, and pressure to improve quality, she encourages healthcare leaders to ask how they can better leverage one of the most accessible healthcare professionals available in nearly every community. Rather than focusing only on what pharmacists dispense, Angel leaves listeners with a broader question: What can pharmacists prevent or help solve? The episode closes, as always, with the reminder that Health IT is a dish best served hot. Prefer video? Catch episodes on the POCP YouTube channel

In this episode, Dr. Jan D. Hirsch, Founding Dean of the University of California, Irvine School of Pharmacy & Pharmaceutical Sciences & Professor of Clinical Pharmacy, discusses how AI, precision medicine, and interdisciplinary education are shaping the future of pharmacy while preparing the next generation of healthcare leaders to improve patient outcomes.

In this episode, Dr. Jan D. Hirsch, Founding Dean of the University of California, Irvine School of Pharmacy & Pharmaceutical Sciences & Professor of Clinical Pharmacy, discusses how AI, precision medicine, and interdisciplinary education are shaping the future of pharmacy while preparing the next generation of healthcare leaders to improve patient outcomes.

In this episode of the JACCP Podcast, host Rob DiDomenico is joined by JACCP Editor in Chief Stuart Haines and Senior Associate Editor Beth Phillips to offer practical guidance for authors seeking to publish in the Journal of the American College of Clinical Pharmacy. With nearly 500 annual submissions and a rejection rate approaching 90% for unsolicited manuscripts, it's important to put together a strong submission. The conversation covers the journal's scope and mission and addresses the most common reasons manuscripts are rejected, from methodological weaknesses to unsupported conclusions. Stuart and Beth also share actionable tips on following reporting guidelines, strengthening review articles, and exploring the journal's full range of manuscript types. A recurring theme: don't hesitate to pitch your idea before investing weeks in writing.

This podcast episode features an interview with Russell Phillips, Amie Pollack, and Dru Ricci from the Center for Primary Care at Harvard Medical School and authors of the Primary Care Investment Guide, with special guest, Todd Sorensen from the University of Minnesota College of Pharmacy. The Primary Care Investment Guide advocates for the integration of clinical pharmacists into primary care teams. The authors explain that their research used a mixed-methods approach, interviewing healthcare leaders from five states and conducting literature reviews, to identify sustainable strategies in primary care settings that enhance patient outcomes and reduce costs. Their findings highlight that clinical pharmacists provide a significant return on investment by managing chronic diseases, optimizing medications, improving medication access, and decreasing hospitalizations. The discussion emphasizes that successful integration can be facilitated by payment reform, moving away from fee-for-service models toward capitated payments and other alternative payment models that support optimal care delivery by primary care teams. Ultimately, the Guide provides a strategic framework for healthcare leaders and policymakers to justify and implement the provision of high-value services in primary care settings.  Funding for the Primary Care Investment Guide was provided by The Commonwealth Fund and the California Health Care Foundation.  You can download the Primary Care Investment Guide here:  https://thepcc.org/reports/2025-primary-care-investment-guide/  

In this month's podcast episode, The Standards, hosts Neil Skolnik, MD, and Sara Wettergreen, PharmD, BCACP, BC-ADM, explain the Standards of Care in Diabetes from the American Diabetes Association® in clear, plain terms. This conversation is designed to help you better understand the guidance that shapes diabetes and obesity care. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to "follow" Diabetes Day by Day!   Additional resources: Access the Standards of Care in Diabetes—2026 Access sections 1-3 of the Standards of Care in Overweight and Obesity Access Your Rights and Care Standards: A Guide for People with Type 2 Diabetes          

Quality Corner Show Host Nick Dorich, PharmD, welcomes back Richard Waithe, PharmD, COO of Pyrls, to discuss the integration of Pyrls with EQUIPP Copilot and how this can supercharge clinical pharmacy workflow.This episode focuses on how this powerful combination is helping pharmacists improve patient outreach, enhance consultations, and drive better health outcomes by dramatically improving access to essential drug information.

80% of migraine sufferers are women. And I hear way too many women say their doctors brush off their complaints of headaches and migraines, giving no real, lasting solutions.  So that ends here!  I've invited the brilliant Dr. Meg Mill on the podcast to unpack the real connection between hormones, histamine, and headaches, especially as it relates to midlife hormonal changes.  You'll learn the first practical steps—like: balancing blood sugar reducing oxidative stress spotting symptom patterns simplifying food eliminations and choosing the right supplements  —to finally get ahead of chronic migraines. This conversation is all about giving you the clarity, tools, and confidence to support your body instead of suffering in silence.  Tune in to discover the migraine solutions every woman deserves! Dr. Meg Mill Dr. Meg Mill is a leading women's health expert, Doctor of Clinical Pharmacy, and Certified Functional Medicine Practitioner with over 20 years of clinical experience. She's the creator of the R.A.D.I.A.N.T. Method, a proprietary root-cause framework that empowers women to rebalance their bodies, regulate their nervous systems, and reclaim their energy and confidence. Through her virtual Functional Medicine practice and membership community, the Women's Wellness Collective, Dr. Meg has guided hundreds of women to lasting relief. A bestselling author and host of the top-rated podcast A Little Bit Healthier, she's a sought-after speaker and summit host.  IN THIS EPISODE Dr. Meg Mill's experience with people suffering from headaches  Avoiding a one-size-fits-all approach to headache management  Understanding a variety of potential migraine triggers  The hormonal component to headaches and migraines  The connection between insulin resistance and headaches  Managing system-wide inflammation to help ease headaches  Specific foods that can contribute to migraines  How to get more support if you're suffering from migraines  QUOTES ”Sometimes it's looking at your hormones in the way you're metabolizing. You may actually have low estrogen… so what we need to look at is how you metabolize your estrogen.”  “The more we can keep our blood sugar balanced throughout the day and night, the better [it is] for migraines.”   “If you can take away any message from this conversation, it's that there's hope and there ARE things you can do [for migraines].” RESOURCES MENTIONED Dr. Meg Mill's FREE GUIDE: Say Goodbye to Headaches Naturally https://go.megmill.com/headaches Order my new book: The Perimenopause Revolution https://peri-revolution.com/ Use code ENERGIZED and get 20% off on your Timeline order http://timeline.com/ENERGIZED Dr. Meg Mill's Website Dr. Meg Mill on Instagram Dr. Meg Mill's Podcast: A Little Bit Healthier RELATED EPISODES  642: The Metabolic Root Cause of Migraines & Powerful Diet and Lifestyle Interventions For Brain Health with Dr. Elena Gross 656: The Dangers Of NOT Prescribing Bioidentical HRT + Migraines, Testosterone and Mitigating Inflammation with Dr. Louise Newson 594: What I Did This Past Year to Heal My Brain and Lower Systemic Inflammation #648: This Changes Everything: The Perimenopause Revolution Every Woman Needs Now

Send us a textDid you know that someone needs blood in the United States every two seconds? Whether it's for surgeries, cancer treatment, traumatic injuries or something else, your blood donation could help save a life. Suzanne Felton, Laboratory manager at St. Luke's, and Adam Wilcox, St. Luke's Clinical Pharmacy manager and a frequent blood donor, join Dr. Arnold to discuss blood donation.If you are interested in donating blood, visit lifeservebloodcenter.org to schedule your donation appointment. Do you have a question about a trending medical topic? Ask Dr. Arnold! Submit your question and it may be answered by Dr. Arnold on the podcast! Submit your questions at: https://www.unitypoint.org/cedarrapids/submit-a-question-for-the-mailbag.aspxIf you have a topic you'd like Dr. Arnold to discuss with a guest on the podcast, shoot us an email at stlukescr@unitypoint.org.

In this episode of Diabetes Day by Day, Drs. Neil Skolnik and Sara Wettergreen talk with Dr. Akturk about the potential health risks associated with cannabis use for people living with diabetes. Cannabis use can affect blood glucose management, heart health, and even how someone manages their medications.  Understanding the risks of cannabis use is an important part of managing diabetes safely. Staying informed and having open conversations with your health care team are the best ways to protect your health. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Halis Kaan Akturk, MD, Associate Professor of Medicine and Pediatrics, Barbara Davis Center for Diabetes, University of Colorado, Aurora, CO Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to "follow" Diabetes Day by Day!

Artificial intelligence, or, AI is on everyone's minds, and we're all still figuring out how to trust it, teach it, and use it responsibly. Today we take a deep dive into how AI is affecting the education of current and future pharmacy students. With us is Jennifer Trujillo, associate Dean for education and professor in the Department of Clinical Pharmacy at the Skaggs School of Pharmacy and Pharmaceutical Sciences on the University of Colorado Anschutz Medical Campus in Aurora, Colorado, and Logan Tinsen, the clinical pharmacy manager and residency program director at Benefis Hospital in Great Falls, Montana.   Guest speakers:  Jennifer Trujillo, PharmD, BCPS, CDCES, BC-ADM Associate Dean for Education Professor, Department of Clinical Pharmacy Skaggs School of Pharmacy and Pharmaceutical Sciences University of Colorado Anschutz Medical Campus Logan Tinsen, PharmD, FMPA Clinical Pharmacy Manager and Residency Program Director Benefits Hospitals   Host:   Kerry Schwarz, PharmD, MPH   Senior Clinical Manager, Evidence-Based Medicine and Outcomes  Center for Pharmacy Practice Excellence (CPPE)   Show Notes:  [01:02-03:45] Challenges with AI in pharmacy education [03:46-05:59] The AI adoption spectrum: Pitfalls of extremes between full and limited adoption [06:00-11:18] Approaches to pharmacy education in the early stages of AI [11:19-14:55] Guardrails and safeguards [14:56-16:29] Key takeaways about AI right now for pharmacy educators   VerifiedRx Listener Feedback Survey: We would love to hear from you - Please click here   Subscribe Today! Apple Podcasts Spotify YouTube RSS Feed

In this episode of Diabetes Day by Day, Drs. Neil Skolnik and Sara Wettergreen talk with Aaron Sutton, LCSW, BCD, CAADC, and Casey Coffman about decision fatigue—what it means and ways to cope, especially as the holiday season approaches. Living with diabetes means making countless decisions every day—from meal choices to medication timing. Over time, this can lead to decision fatigue, impacting both your mental health and diabetes management. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Aaron Sutton, LCSW, BCD, CAADC, Director of the Sutton Institute for Psychotherapy Casey Coffman, American Diabetes Association® volunteer and a person living with type 1 diabetes Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to "follow" Diabetes Day by Day!

Join Drs. Neil Skolnik and Sara Wettergreen as they answer one of the most common questions people living with diabetes have: “What diabetes medication is best for me?”   In this episode, they'll explore how choosing the right medication depends on your individual health, lifestyle, and goals. Discover practical tips to better help you work with your care team to make informed decisions and find the best treatment plan for you.   Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   Diabetes Medications: Biguanides Brand: Glucophage, Fortamet, Glumetza Generic: Metformin, Metformin XR Sulfonylureas (Second Generation) Brand: Glucotrol, Amaryl, Diaβeta, Glynase Generic: Glipizide, Glipizide XL, Glimepiride, Glyburide Thiazolidinediones (TZDs) Brand: Actos, Avandia Generic: Pioglitazone, Rosiglitazone (no longer available) DPP-4 Inhibitors Brand: Januvia, Onglyza, Tradjenta, Nesina Generic: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin SGLT2 Inhibitors Brand: Invokana, Farxiga, Jardiance, Steglatro, Brenzavvy Generic: Canagliflozin, Dapagliflozin, Empagliflozin, Ertugliflozin, Bexagliflozin GLP-1 Receptor Agonists Brand: Victoza, Trulicity, Ozempic, Rybelsus, Mounjaro (dual GIP/GLP-1) Generic: Liraglutide, Dulaglutide, Semaglutide, Tirzepatide Insulins (selected examples) Brand: Humalog, NovoLog, Apidra, Lantus, Basaglar, Levemir, Tresiba, Humulin N, Novolin N, Humulin R, Novolin R Generic: Insulin lispro, Insulin aspart, Insulin glulisine, Insulin glargine, Insulin detemir, Insulin degludec, NPH insulin, Regular insulin

Listen in as our expert panel discusses the latest recommendations for managing medications after heart attacks and other cardiac events. You'll hear our panelists review which antiplatelets to use, the optimal blood pressure meds, and the role of statin and non-statin cholesterol meds.Special guests:Danielle Blais, PharmD, FCCP, BCCP, BCPSCardiology Lead Specialty Practice PharmacistRichard M. Ross Heart HospitalThe Ohio State University Wexner Medical CenterJoel C. Marrs, PharmD, MPH., BCACP, BCCP, BCPS, FAHA, FASHP, FCCP, FNLAProfessor and Coordinator of Clinical OutreachThe University of Tennessee Health Science CenterDepartment of Clinical Pharmacy & Translational ScienceYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Andrea Darby-Stewart, MDAssociate Director, Honor Health Family Medicine Residency ProgramClinical Professor of Family, Community & Occupational MedicineThe University of Arizona College of Medicine – PhoenixCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in July 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Dual Antiplatelet Therapy for Coronary Artery DiseaseComparison of Oral Beta-BlockersAngiotensin Receptor Blockers and Angiotensin-Converting Enzyme InhibitorsCholesterol Guidelines (United States)Non-Statin Lipid-Lowering AgentsSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

In this podcast, leaders from schools of pharmacies, residency program directors, and health-system pharmacy chiefs discuss why there are declining enrollment numbers in residency programs and what the implications are for the future of clinical pharmacy. In part two of this series, we will explore what are the implications behind the numbers and what health systems can do to support the clinical pharmacists of tomorrow.   The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Celebrate the American Diabetes Association®'s (ADA) 85th anniversary with Drs. Neil Skolnik and Sara Wettergreen, joined by Dr. Marlon Pragnell, Charlene Wallace, and Stacey Krawczyk. Together, they'll reflect on the ADA's legacy of groundbreaking research and how it continues to shape the programs and resources available today. The conversation will also highlight practical tools—from nutrition guidance to the National Diabetes Prevention Program—to support you and your loved ones in managing or preventing diabetes. Because it all matters. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Marlon Pragnell, PhD, Vice President of Research and Science at the ADA Charlene Wallace, MBA, Vice President of Diabetes Prevention at the ADA Stacey Krawczyk, MS, RD, Director of Nutrition and Wellness at the ADA Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   Additional resources: Research Impact   Learn More About the National Diabetes Prevention Program    Eating for Diabetes Management   Diabetes Food Hub   More on the ADA's 85th Anniversary

Edel Burton, Clinical Hospital Pharmacist and Lecturer in Clinical Pharmacy in University of College Cork, discusses her recent study on prehospital care for suspected stroke during the COVID-19 pandemic. She discusses methods, findings, and what she's going to research next.For Your Information:Edel's episode about her benchmarking study: https://www.aedrjournal.org/speaking-the-same-language-with-edel-burton Edel's ORCID site: https://orcid.org/0000-0002-5847-0174

ASHP's senior education director, Cindy Von Heeringen is joined by Angela Goodhart, associate professor of Clinical Pharmacy and Family Medicine at West Virginia University, as she discusses her upcoming Midyear sessions that focuses on key components for a successful residency interview and defining characteristics and values of the different generations.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Why is enrollment in residency programs dropping? And what does this decline mean for clinical pharmacists? In this podcast, leaders from schools of pharmacies, residency program directors, and health-system pharmacy chiefs discuss why there are declining enrollment numbers in residency programs and what the implications are for the future of clinical pharmacy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, listen to Kelly Romo, PharmD, BCOP; and Shauna Kraft, PharmD, BCOP, share their takeaways from a live webinar on available emerging subcutaneous immunotherapy options for patients with cancer including:Basic mechanism of action and role of hyaluronidase in subcutaneous immunotherapy formulation and available dosing/schedulesAvailable pharmacodynamics/pharmacokinetics, efficacy, and safety data for subcutaneous immunotherapy formulationsCurrent and potential models for administration of subcutaneous immunotherapy in the inpatient setting and day-to-day considerationsPresenters:Kelly Romo, PharmD, BCOPManager, Oncology Medical Drug Management and Customer InitiativesBlue Cross Blue Shield MichiganDetroit, MichiganShawna Kraft, PharmD, BCOPClinical Pharmacist, SpecialistMichigan Medicine, Rogel Cancer CenterClinical Associate ProfessorUniversity of Michigan College of PharmacyAnn Arbor, MichiganResources:Consolidate your learning with a recording from an on-demand webcast, download the slides associated with this discussion, or read an expert text module or commentary on this topic. 

In this episode, listen to Kelly Romo, PharmD, BCOP; and Shauna Kraft, PharmD, BCOP, share their takeaways from a live webinar on available emerging subcutaneous immunotherapy options for patients with cancer including:Basic mechanism of action and role of hyaluronidase in subcutaneous immunotherapy formulation and available dosing/schedulesAvailable pharmacodynamics/pharmacokinetics, efficacy, and safety data for subcutaneous immunotherapy formulationsCurrent and potential models for administration of subcutaneous immunotherapy in the inpatient setting and day-to-day considerationsPresenters:Kelly Romo, PharmD, BCOPManager, Oncology Medical Drug Management and Customer InitiativesBlue Cross Blue Shield MichiganDetroit, MichiganShawna Kraft, PharmD, BCOPClinical Pharmacist, SpecialistMichigan Medicine, Rogel Cancer CenterClinical Associate ProfessorUniversity of Michigan College of PharmacyAnn Arbor, MichiganResources:Consolidate your learning with a recording from an on-demand webcast, download the slides associated with this discussion, or read an expert text module or commentary on this topic. 

Join Drs. Neil Skolnik and Sara Wettergreen as they discuss key takeaways from the ADA's 85th Scientific Sessions in Chicago, highlighting advancements in diabetes and obesity care. With guests, Drs. Osagie Ebekozien and Marlon Pragnell, they'll explore how these advancements can positively impact you and your loved ones.   Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Osagie Ebekozien, MD, MPH, CPHQ, Chief Quality Officer at the ADA  Marlon Pragnell, PhD, Vice President of Research and Science at the ADA Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   Additional resources: Patient Standards of Care 2025 Need information on diabetes, ADA programs, or upcoming events? The ADA's Center for Information is here to help. Contact them directly at 1-800-DIABETES (1-800-342-2383) or email AskADA@diabetes.org for personalized guidance and support.

Podcast host and JACCP Editor-in-Chief, Stuart T. Haines, and guests, Leigh Ann Ross, Dean and Bell Endowed Chair at the Auburn University Harrison College of Pharmacy,  and Zack Dumont, Manager of Clinical Pharmacy for the Saskatchewan Health Authority. discuss the recently released ACCP Commentary titled "Framework and recommendations to support bidirectional information sharing between community pharmacies and other health care setting.”Here's what you'll learn:Why bidirectional information exchange between all settings of care, including community pharmacies, is important for ACCP, the pharmacy profession, and society.How Kotter's change management framework can be applied to achieve this goal.Key barriers to successful bidirectional health information exchange and potential solutions.The ACCP Commentary was published in JACCP online in March 2025 and in the May 2025 issue of the journal.

 Tune in to this episode featuring Drs. Neil Skolnik and Sara Wettergreen as they explore the power of storytelling and how it brings us together. Special guests Marlee Seibold and Dr. Saige Kiedinger shared their personal experiences with type 1 diabetes, including— challenges, triumphs, and the everyday moments that have shaped their journeys. We hope that by listening to their stories, you'll gain a deeper understanding of the power of storytelling and feel inspired to share your own journey. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Marlee Seibold: Storytelling Communications Manager at the ADA and a person living with type 1 diabetes.   Dr. Saige Kiedinger: A recent pharmacy school graduate transitioning to residency training, also living with type 1 diabetes.   Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   Want to share your journey with us? Share it now here.

Join Drs. Neil Skolnik and Sara Wettergreen in this episode as they discuss the importance of emotional wellbeing in overall health. They will explore the connection between mental health and diabetes, focusing on how managing a chronic condition can impact the emotional lives of people living with diabetes and their families. Special guest Dr. Kelsey Brzezinski will also join the conversation.   Please note that this episode includes discussions of sensitive topics, we encourage you to listen with care and understand that the American Diabetes Association® is not an organization that specializes in mental health and only seeks to bring awareness to factors that coincide with a diabetes diagnosis. If you are experiencing challenges seek the support of a licensed medical or mental health professional. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Kelsey Brzezinski, PhD, Pediatric Psychologist at Lurie Children's Hospital of Chicago, Assistant Professor of Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine, Chicago, IL   Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   Additional resources: If you or a loved one are experiencing a mental health crisis, please call the 988 Suicide & Crisis Lifeline. SAMHSA mental health help line, which is a no-cost, confidential, 24/7, 365-day-a-year treatment referral and information service available at 1-800-662-HELP (4357). Check out the American Diabetes Association®'s newly updated Mental Health Provider Directory to find to find therapists who specialize in supporting people living with diabetes near you.  

Hospitals today face rising drug costs, workforce shortages, supply chain disruptions and tightening reimbursement, making financial sustainability increasingly difficult to achieve. In this episode of Healthcare Insider, Cardinal Health's Mike Brown, R.Ph, vice president of managed services, and Michelle Dalton, PharmD, regional director of account management and operations, discuss how a strategic approach to pharmacy management can help hospitals of all sizes reduce costs, optimize operations and unlock new revenue streams. They also share how one Southeastern health system kept $3 million in clinical savings in one year by transforming pharmacy operations. Listen to learn how your organization can tap into the pharmacy's full potential to drive financial resilience and growth across your system.

A new episode of Diabetes Day by Day is here! Join Drs. Neil Skolnik and Sara Wettergreen as they share tips to increase movement in honor of April being Move More Month. Since we're all about movement and exercise, we're excited to welcome special guests Adrienne Edge and David Rachal III from the American Diabetes Association®'s (ADA) Project Power program. They'll share how you can get involved and start moving to stay healthy, prevent, or better manage type 2 diabetes. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Adrienne Edge, Founder of ProFIT Family Wellness, Community Partner and Facilitator Trainer for the ADA's Project Power program   David Rachal III, Nationally Respected Leader in Medical Fitness, Wellness, and Entrepreneurial Empowerment, Community Partner and Facilitator Trainer for the ADA's Project Power program   Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   To learn more about Project Power, be sure to check out: diabetes.org/ProjectPower.

Drs. Adrian Wong, Sandra Kane-Gill, and Alexandre Chan discuss their ACCP Committee work with associate editor, Dr. Alan Zillich. The committees' work resulted in two papers describing the current and future role of AI in clinical pharmacy practice, research, and scholarship. Read the full-text manuscripts: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70004 and https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70003.

On March 19. 2025, The American College of Clinical Pharmacy published, "A review of antibiotic safety in pregnancy- 2025 Update". In this episode, we will review some of the confusion surrounding aminoglycosides, sulfa, and nitrofurantoin in pregnancy. Its interesting how different professions view certain medications in pregnancy. Does ACOG say you can use Sulfa in the third trimester? Can you use nitrofurantoin in the first trimester? Listen in for details. (SHOUT OUT to our partner podcast, CLINICAL PEARLS LATINO, for the topic idea. GRACIAS AMIGOS)

Join Drs. Neil Skolnik and Sara Wettergreen as they delve into the differences between FDA-approved medications and compounded and counterfeit medications, alongside special guests Dr. Susan Kuchera and Lisa Kessler. They will explore the factors that might influence the decision to use compounded treatments, the risks associated with these treatments, and one of our guests will share their personal experience with obesity treatment. This episode of Diabetes Day by Day is supported by Lilly. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Susan Kuchera, MD, Clinical Assistant Professor of Family and Community Medicine at the Sidney Kimmel Medical College of Thomas Jefferson University and Program Director of the Family Medicine Residency at Jefferson Health Abington   Lisa Kessler, MS, CCC-SLP, Infant-toddler Home-based Pediatric Speech-Language Pathologist   Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day! Learn more about the risks of buying medications online at the BeSafeRx website, the Food and Drug Administration's source for online pharmacy information. Read the American Diabetes Association®'s statement on compounded medications. 

Hospital clinical pharmacies play a key role in ensuring patients are taking medications effectively and supporting other providers who are managing their care. Mark Riggle, the assistant chief pharmacy officer at UC Davis Health, explains how 340B helps make this direct care and ancillary support possible.Clinical pharmacies are a bridge between providers and patientsRiggle says clinical pharmacy teams serve as drug experts that can help teach patients about potential side effects and how to take their medications properly. But these teams also can take the lead on supporting other providers on refills, prior authorizations, financial assistance, and more. That allows the other providers to focus less on those processes and more on providing medical care to the patients. In-house pharmacies can improve patient care and generate revenueUsing an in-house clinical pharmacy has benefits for both patients and the hospital. Riggle notes that keeping prescriptions and pharmacy support in-house can enable hospitals to keep better track of patients' health and identify if there are issues or questions with certain medications. At the same time, it generates revenue and 340B savings that support even more hospital services and improve patient health outcomes even more.Ramping up clinical pharmacy services and overcoming barriers can take timeRiggle says expanding clinical pharmacy initiatives at UC Davis Health has come with some challenges. It took years to roll out a refill program for all the providers who needed that support, and achieving success with a prior authorization program involved an evaluation of workflows to improve efficiency. But he noted that hospital pharmacists can present a value proposition to their leaders for how investing in 340B-supported clinical pharmacy services can be worth it to improve care quality and provider satisfaction.ResourcesFederal Judge Allows 340B Health, Member Hospitals To Intervene in Rebate Lawsuits

Crystal Zhou, PharmD, APh, AHSCP, BCACP, joined Over the Counter to discuss The Cut Hypertension Program, which operates in barbershops across the Bay Area in California. Zhou is the program's Lead Pharmacist and she is also an Associate Professor in the Department of Clinical Pharmacy at the University of California, San Francisco.

A new episode of Diabetes Day by Day is here! Join Drs. Neil Skolnik and Sara Wettergreen as they dive into the world of mobile health technology and how it's shaping diabetes management. With so many apps for tracking blood glucose (blood sugar), counting carbs, and logging fitness activities, it can be tough to find the right one. In this episode, we welcome Susan Weiner, MS, RDN, CDCES, FADCES, a nutrition, health, and diabetes expert with knowledge of diabetes-related apps, and Bridget Wood, RD, LD, CDCES, who has lived with type 1 diabetes for over 15 years and has firsthand experience with apps that can assist with diabetes management. Our guests will share valuable insights on how apps can support people living with diabetes and why using them can be beneficial. This episode isn't sponsored, and we're not endorsing any specific app—just sharing examples of ones that have helped others. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Susan Weiner, MS, RDN, CDCES, FADCES — Columnist at Endocrine Today, Owner of Susan Weiner Nutrition, PLLC, and Nutrition Communicator and Media Consultant, New York City Metropolitan Area Bridget Wood, RD, LD, CDCES — Owner and Clinical Director of Bridget Wood Wellness, LLC, Reno, NV Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day! For additional resources, be sure to check out: FDA Alert DiabetesWise ADCES Danatech Apps and Platforms Phone apps referenced: Glucose Blood Sugar Tracker Dario Health Livongo by Teladoc Health mySugr Dexcom G7 Tidepool OMRON (for blood pressure)

Hennepin EMS in Minnesota is breaking new ground in prehospital care with the introduction of a clinical pharmacist consulting role, designed to tackle complex challenges and foster collaboration between paramedics and pharmacists through hands-on support and cutting-edge research. The clinical pharmacist acts as a bridge between hospital and field operations, ensuring prehospital teams have the support they need to improve patient outcomes. A critical part of the pharmacist's responsibilities includes hands-on engagement. From participating in ambulance ride-alongs to hosting open-door consultations, this role prioritizes practical and actionable solutions. At the heart of this initiative is Holly Drone, PharmD, Hennepin EMS's clinical pharmacist. Not only has Holly been integral to placing this program into action, but she's also contributing to the field through her research. Her studies focus on essential topics such as Sodium Nitrate Overdose management, the initiation of Buprenorphine in prehospital settings, and the use of Oral Risperidone by EMS providers in the field. To learn more about this innovative role and hear directly about her experiences and research, check out her recent interview on the podcast “EMS Research with Professor Bram.” Holly provides unique insights into the evolving relationship between paramedics and pharmacists as well as the critical role clinical pharmacy plays in improving prehospital care.

High phosphorus (hyperphosphatemia) is a common complication caused by chronic kidney disease. Join us for this NKF Live to learn more about why this happens and how to successfully manage high phosphorus in CKD. During this program, you will hear a kidney doctor, a clinical pharmacist, and a person living with high phosphorus discuss important information to know about when managing high phosphorus.   Dr. Jay Wish is Professor of Clinical Medicine at Indiana University School of Medicine in Indianapolis and Chief Medical Officer for Outpatient Dialysis at Indiana University Health.  He is past president of the National Forum of ESRD Networks, served on the Board of Directors of the Renal Physicians Association and the American Association of Kidney Patients and was the recipient of the latter's Visionary Award in 2005. He has over 150 articles, reviews, and book chapters published, particularly in the areas of ESRD quality oversight/improvement, accountability, anemia management and vascular access. Dr. Katie Cardone is an associate professor at Albany College of Pharmacy and Health Sciences in Albany, NY. She is a clinical pharmacist with a clinical practice and research program focused on improving care in patients with kidney disease in outpatient nephrology and dialysis. She co-led the publication of pharmacy practice standards for pharmacists caring for people with kidney disease. She is a member of the Board of Pharmacy Specialties Ambulatory Care Pharmacy Council and is a fellow of the National Kidney Foundation, the American Society of Nephrology, and the American College of Clinical Pharmacy. Quenton Turner Gee has been on in-center hemodialysis for about 2 years. He was diagnosed with Stage 4 CKD in 2020. After a battle with COVID-19, it quickly progressed to end-stage kidney disease. Since starting on dialysis, he's been advocating for mental health and policies improving access to transplants and kidney innovations.   Additional Resources: Phosphate Lowering Agents High Phosphorus Information NKF Peers   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.

A new year brings a new episode of Diabetes Day by Day! Join Drs. Neil Skolnik and Sara Wettergreen as they provide an overview of the ADA's Standards of Care in Diabetes—2025 and discuss their significance. They will also explore new updates you can bring up with your primary care provider during your next visit, including recommendations for using diabetes technology, weight management strategies, including medication therapy, and the latest insights on nutrition.  Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

Equitable biomarker testing access, including pharmacogenomics testing, is critical for patients to experience optimal medication therapy outcomes. Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, Dr. Behnaz Sarrami, and Hilary Goeckner, Director of State & Local Campaigns - Access to Care of the American Cancer Society Cancer Action Network (ACS CAN), educate listeners about ACS CAN's mission, how it executes on its mission, accomplishments, and future goals.  This episode is a must listen for anyone who wants the latest update on the American Cancer Society Cancer Action Network's work influencing state legislatures to pass legislation to expand coverage of biomarker testing, states who have already passed legislation and those with pending legislation, and to learn how they too can advocate.   After listening to this episode, listeners will be able to describe biomarker testing's importance in healthcare; describe how the American Cancer Society Cancer Action Network is championing biomarker testing coverage legislation; name states that have passed biomarker testing legislation and those with pending legislation; know how one can contribute to the efforts to increase biomarker testing coverage. Hilary Gee Goeckner is director of state and local campaigns for the American Cancer Society Cancer Action Network (ACS CAN), the advocacy affiliate of the American Cancer Society. In this role she leads work with ACS CAN staff and coalition partners across the country to improve access to comprehensive biomarker testing, clinical trials, fertility preservation and other health care access issues. Prior to this role, Hilary served as the Kansas government relations director for ACS CAN. Before joining ACS CAN, Hilary served as director of health policy at Kansas Action for Children. She holds a bachelor's degree in anthropology and global health from Williams College and a master's degree in social work from Boston College. She lives in San Diego with her husband and two children. As the CEO of inGENEious RX Incorporated and pharmacogenomics subject matter expert, Dr. Becky Winslow has dedicated over a decade to providing innovative solutions for pharmacogenomics stakeholders. Her extensive experience also includes directing pharmacy operations and medication safety programs across diverse clinical settings, spanning retail, hospital, long-term care, and public health. Dr. Winslow is a passionate educator, training Doctors of Clinical Pharmacy to work with molecular testing stakeholders and serving as an advanced pharmacy practice preceptor for Manchester University's Master of Science in Pharmacogenomics Program. She hosts an evidence-based educational podcast, The Precision Health and PGx Podcast, which Welp Magazine recognized as the ninth most listened to genetics podcast globally. Her involvement with prominent organizations like the Clinical Pharmacogenetics Implementation Consortium and the National Council for Prescription Drug Programs (NCPDP) PGx Task Force speaks to her expertise and commitment. Dr. Winslow frequently presents at national conferences such as The Association for Molecular Pathology and holds degrees from Campbell University.  Behnaz Sarrami, PharmD, MS, is a leading expert in pharmacogenomics and a dedicated Medical Science Liaison (MSL). She is named American Pharmacists Association's (APhA) "50 Most Influential Leaders in Pharmacy" and Medika's "Top 30 Women Transforming Healthcare". Behnaz is passionate about advancing personalized medicine to optimize treatments and improve patient outcomes, especially in underserved populations. She supports healthcare professionals through scientific training and presentations. As the host of the "Precision Health and PGx" podcast, she mentors pharmacists transitioning into MSL roles and those launching pharmacogenomics consulting careers. She earned her Master's in Biochemistry from Georgetown University and her Doctorate in Pharmacy from Creighton University. With significant contributions to research and education, she continues to drive innovation in pharmacogenomics through her work with healthcare professionals and community outreach programs.  

Equitable biomarker testing access, including pharmacogenomics testing, is critical for patients to experience optimal medication therapy outcomes. Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, Dr. Behnaz Sarrami, and Hilary Goeckner, Director of State & Local Campaigns - Access to Care of the American Cancer Society Cancer Action Network (ACS CAN), educate listeners about ACS CAN's mission, how it executes on its mission, accomplishments, and future goals.  This episode is a must listen for anyone who wants the latest update on the American Cancer Society Cancer Action Network's work influencing state legislatures to pass legislation to expand coverage of biomarker testing, states who have already passed legislation and those with pending legislation, and to learn how they too can advocate.   After listening to this episode, listeners will be able to describe biomarker testing's importance in healthcare; describe how the American Cancer Society Cancer Action Network is championing biomarker testing coverage legislation; name states that have passed biomarker testing legislation and those with pending legislation; know how one can contribute to the efforts to increase biomarker testing coverage. Hilary Gee Goeckner is director of state and local campaigns for the American Cancer Society Cancer Action Network (ACS CAN), the advocacy affiliate of the American Cancer Society. In this role she leads work with ACS CAN staff and coalition partners across the country to improve access to comprehensive biomarker testing, clinical trials, fertility preservation and other health care access issues. Prior to this role, Hilary served as the Kansas government relations director for ACS CAN. Before joining ACS CAN, Hilary served as director of health policy at Kansas Action for Children. She holds a bachelor's degree in anthropology and global health from Williams College and a master's degree in social work from Boston College. She lives in San Diego with her husband and two children. As the CEO of inGENEious RX Incorporated and pharmacogenomics subject matter expert, Dr. Becky Winslow has dedicated over a decade to providing innovative solutions for pharmacogenomics stakeholders. Her extensive experience also includes directing pharmacy operations and medication safety programs across diverse clinical settings, spanning retail, hospital, long-term care, and public health. Dr. Winslow is a passionate educator, training Doctors of Clinical Pharmacy to work with molecular testing stakeholders and serving as an advanced pharmacy practice preceptor for Manchester University's Master of Science in Pharmacogenomics Program. She hosts an evidence-based educational podcast, The Precision Health and PGx Podcast, which Welp Magazine recognized as the ninth most listened to genetics podcast globally. Her involvement with prominent organizations like the Clinical Pharmacogenetics Implementation Consortium and the National Council for Prescription Drug Programs (NCPDP) PGx Task Force speaks to her expertise and commitment. Dr. Winslow frequently presents at national conferences such as The Association for Molecular Pathology and holds degrees from Campbell University.  Behnaz Sarrami, PharmD, MS, is a leading expert in pharmacogenomics and a dedicated Medical Science Liaison (MSL). She is named American Pharmacists Association's (APhA) "50 Most Influential Leaders in Pharmacy" and Medika's "Top 30 Women Transforming Healthcare". Behnaz is passionate about advancing personalized medicine to optimize treatments and improve patient outcomes, especially in underserved populations. She supports healthcare professionals through scientific training and presentations. As the host of the "Precision Health and PGx" podcast, she mentors pharmacists transitioning into MSL roles and those launching pharmacogenomics consulting careers. She earned her Master's in Biochemistry from Georgetown University and her Doctorate in Pharmacy from Creighton University. With significant contributions to research and education, she continues to drive innovation in pharmacogenomics through her work with healthcare professionals and community outreach programs.  

A new episode of Diabetes Day by Day is here! Join Drs. Neil Skolnik and Sara Wettergreen as they delve into the topic of heart failure. They'll discuss steps you can take if you're living with diabetes to prevent it or detect it early, and receive timely treatment for better outcomes.  In this episode, we welcome guest Jim Januzzi, MD, Professor of Medicine at Harvard Medical School, Cardiologist at Massachusetts General Hospital, and Chief Scientific Officer at the Baim Institute for Clinical Research. Dr. Januzzi has published more than 900 manuscripts, edited 5 textbooks, and serves as a Deputy Editor at the Journal of the American College of Cardiology. He is a nationally recognized lecturer on the testing and treatment of heart failure. Dr. Januzzi will share valuable insights to help people living with diabetes, no matter where they are in their journey, as it relates to heart health and heart failure.  This episode of Diabetes Day by Day is supported by Roche. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Jim Januzzi, MD, Professor of Medicine at Harvard Medical School, Cardiologist at Massachusetts General Hospital, and Chief Scientific Officer at the Baim Institute for Clinical Research Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!  

Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, Dr. Behnaz Sarrami, and Dr. Jeremy Stuart, Chief Scientific Officer and laboratory director for Precision Genetics, discuss pharmacists value as employees in clinical pharmacogenomics testing laboratories. Having employed pharmacists in his laboratories, Dr. Stuart will provide his first-hand examples to illustrate how pharmacists have benefited his laboratories. Dr. Winslow and Dr. Sarrami will also share their real-world experiences working for clinical pharmacogenomics laboratories to help the laboratory achieve its goals. This episode is a must listen for laboratories who are vested in their pharmacogenomics testing's financial success.  After listening to this episode, the learner will be able to describe responsibilities and roles in pharmacogenomics pharmacists fulfill in clinical labs, name specific real-world examples that illustrate pharmacists' contributions to pharmacogenomics in the clinical laboratory, and name education, training, and work experiences that prepare pharmacists to assume advanced practice roles in clinical laboratories.   Dr. Jeremy Stuart has extensive experience in the life science industry. He specializes in commercial operations, technology development and transfer, manufacturing design, and validation of laboratory developed tests (LDTs). He currently serves as the Chief Scientific Officer for Precision Genetics and serves as their Laboratory Director.  Dr. Stuart was part of the senior management team that completed a management buyout of Lab21 Inc. to form Selah Genomics and the subsequent sale of Selah to EKF. Dr. Stuart led the development and validation of all of Selah's molecular assays and oversaw their clinical studies. Dr. Stuart was also a member of the Agencourt Personal Genomics team, where he co-developed the SOLiD next-generation sequencing technology that was subsequently acquired by Applied Biosystems.   Before entering industry, Dr. Stuart completed his postdoctoral work at the the Harvard School of Public Health, earned his master's degree in Toxicology from the University of Minnesota, and his doctorate in Genetics & Complex Diseases from Harvard University.  As the CEO of inGENEious RX Incorporated and pharmacogenomics subject matter expert, Dr. Becky Winslow has dedicated over a decade to providing innovative solutions for pharmacogenomics stakeholders. Her extensive experience also includes directing pharmacy operations and medication safety programs across diverse clinical settings, spanning retail, hospital, long-term care, and public health. Dr. Winslow is a passionate educator, training Doctors of Clinical Pharmacy to work with molecular testing stakeholders and serving as an advanced pharmacy practice preceptor for Manchester University's Master of Science in Pharmacogenomics Program. She hosts an evidence-based educational podcast, The Precision Health and PGx Podcast, which Welp Magazine recognized as the ninth most listened to genetics podcast globally. Her involvement with prominent organizations like the Clinical Pharmacogenetics Implementation Consortium and the National Council for Prescription Drug Programs (NCPDP) PGx Task Force speaks to her expertise and commitment. Dr. Winslow frequently presents at national conferences such as The Association for Molecular Pathology and holds degrees from Campbell University.  Behnaz Sarrami, PharmD, MS, is a leading expert in pharmacogenomics and a dedicated Medical Science Liaison (MSL). She is named American Pharmacists Association's (APhA) "50 Most Influential Leaders in Pharmacy" and Medika's "Top 30 Women Transforming Healthcare". Behnaz is passionate about advancing personalized medicine to optimize treatments and improve patient outcomes, especially in underserved populations. She supports healthcare professionals through scientific training and presentations. As the host of the "Precision Health and PGx" podcast, she mentors pharmacists transitioning into MSL roles and those launching pharmacogenomics consulting careers. She earned her Master's in Biochemistry from Georgetown University and her Doctorate in Pharmacy from Creighton University. With significant contributions to research and education, she continues to drive innovation in pharmacogenomics through her work with healthcare professionals and community outreach programs.

Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, Dr. Behnaz Sarrami, and Dr. Jeremy Stuart, Chief Scientific Officer and laboratory director for Precision Genetics, discuss pharmacists value as employees in clinical pharmacogenomics testing laboratories. Having employed pharmacists in his laboratories, Dr. Stuart will provide his first-hand examples to illustrate how pharmacists have benefited his laboratories. Dr. Winslow and Dr. Sarrami will also share their real-world experiences working for clinical pharmacogenomics laboratories to help the laboratory achieve its goals. This episode is a must listen for laboratories who are vested in their pharmacogenomics testing's financial success.  After listening to this episode, the learner will be able to describe responsibilities and roles in pharmacogenomics pharmacists fulfill in clinical labs, name specific real-world examples that illustrate pharmacists' contributions to pharmacogenomics in the clinical laboratory, and name education, training, and work experiences that prepare pharmacists to assume advanced practice roles in clinical laboratories.   Dr. Jeremy Stuart has extensive experience in the life science industry. He specializes in commercial operations, technology development and transfer, manufacturing design, and validation of laboratory developed tests (LDTs). He currently serves as the Chief Scientific Officer for Precision Genetics and serves as their Laboratory Director.  Dr. Stuart was part of the senior management team that completed a management buyout of Lab21 Inc. to form Selah Genomics and the subsequent sale of Selah to EKF. Dr. Stuart led the development and validation of all of Selah's molecular assays and oversaw their clinical studies. Dr. Stuart was also a member of the Agencourt Personal Genomics team, where he co-developed the SOLiD next-generation sequencing technology that was subsequently acquired by Applied Biosystems.   Before entering industry, Dr. Stuart completed his postdoctoral work at the the Harvard School of Public Health, earned his master's degree in Toxicology from the University of Minnesota, and his doctorate in Genetics & Complex Diseases from Harvard University.  As the CEO of inGENEious RX Incorporated and pharmacogenomics subject matter expert, Dr. Becky Winslow has dedicated over a decade to providing innovative solutions for pharmacogenomics stakeholders. Her extensive experience also includes directing pharmacy operations and medication safety programs across diverse clinical settings, spanning retail, hospital, long-term care, and public health. Dr. Winslow is a passionate educator, training Doctors of Clinical Pharmacy to work with molecular testing stakeholders and serving as an advanced pharmacy practice preceptor for Manchester University's Master of Science in Pharmacogenomics Program. She hosts an evidence-based educational podcast, The Precision Health and PGx Podcast, which Welp Magazine recognized as the ninth most listened to genetics podcast globally. Her involvement with prominent organizations like the Clinical Pharmacogenetics Implementation Consortium and the National Council for Prescription Drug Programs (NCPDP) PGx Task Force speaks to her expertise and commitment. Dr. Winslow frequently presents at national conferences such as The Association for Molecular Pathology and holds degrees from Campbell University.  Behnaz Sarrami, PharmD, MS, is a leading expert in pharmacogenomics and a dedicated Medical Science Liaison (MSL). She is named American Pharmacists Association's (APhA) "50 Most Influential Leaders in Pharmacy" and Medika's "Top 30 Women Transforming Healthcare". Behnaz is passionate about advancing personalized medicine to optimize treatments and improve patient outcomes, especially in underserved populations. She supports healthcare professionals through scientific training and presentations. As the host of the "Precision Health and PGx" podcast, she mentors pharmacists transitioning into MSL roles and those launching pharmacogenomics consulting careers. She earned her Master's in Biochemistry from Georgetown University and her Doctorate in Pharmacy from Creighton University. With significant contributions to research and education, she continues to drive innovation in pharmacogenomics through her work with healthcare professionals and community outreach programs.

There's Nothing Like It is the theme for the ASHP Midyear Clinical Meeting 2024 and there's nothing like developing your clinical pharmacy leadership skills. Join experienced conference attendees and upcoming speakers presenting at the meeting to learn more about all Midyear has to offer!  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Before founding inGENEious RX Incorporated, a boutique pharmacogenomics consulting firm, Dr. Winslow directed pharmacy business operations and clinical pharmacy programs in retail, hospital, long-term care, and public health pharmacies for Walmart Stores, Community Health Systems, Neil Medical Group, and the North Carolina Department of Health and Human Services. Since founding inGENEious RX over eleven years ago, Dr. Winslow has worked with numerous distinguished vendors in the pharmacogenomics industry including Translational Software, Admera Health, Genemarkers, National Association of Chain Drug Stores, Kentucky Teachers' Retirement System, GenXys, and Thermo Fisher Scientific.  A sought-after pharmacogenomics subject matter expert, Dr. Winslow, has authored PGx payer databases and billing and coding algorithms and served Mintz Law as the expert medical necessity reviewer of Medicare PGx claims. She is an authority in pharmacogenomics access and reimbursement and specializes in business strategy consulting for pharmacogenomics stakeholders.   Dr. Winslow is an Advanced Pharmacy Practice Experience preceptor for Manchester University School of Pharmacy PharmD/Masters in PGx students and a registered trainer for the University of Pittsburgh's Test2Learn (TM) Community PGx Certificate Program. Dr. Winslow is a member of the Clinical Pharmacogenetics Implementation Consortium, the NCPDP PGx Task Force, and the Get the Medications Right Institute.  In 2021, Welp Magazine recognized Dr. Winslow's podcast, the PGx for Pharmacists Podcast, as the world's ninth most listened-to genetics podcast. Her podcast shares the top 20 most listened-to genomics podcast list with genomics podcasts created by such notable podcasters as the National Cancer Institute and the American Heart Association. The Pharmacy Podcast Network recognized Dr. Winslow in 2021 as a Top 50 pharmacy influencer. Entities frequently recruit Dr. Winslow to present PGx topics. She has presented at conferences for the National Association of Boards of Pharmacy, the National Association of Specialty Pharmacy, the Inovalon Customer Congress, and the Association for Molecular Pathology and on the Labroots' and Precision Medicine Institute's platforms.  Dr. Winslow earned her Bachelor of Science in Biology and Doctor of Clinical Pharmacy degrees from Campbell University. Lexi Wensel is a 2024 Manchester University School of Pharmacy graduate where she earned her Doctorate in Pharmacy and Masters in Pharmacogenomics. When this episode was recorded in April 2024, Lexi was completing an advanced pharmacy practice experience with Dr. Becky Winslow, preceptor for Manchester University School of Pharmacy. While studying to become a pharmacist, Lexi gained practical clinical pharmacy experience while working as a pharmacy intern at both Meijer pharmacy and Marion Health Hospital.   Beyond her academic and professional endeavors, Lexi is deeply committed to giving back to the community. She serves as a board member for an organization called Guatemala Family Development where she contributed to initiatives aimed at improving healthcare access and promoting wellness in underserved communities. At the time this episode was recorded, Lexi was completing an advanced pharmacy practice experience with Dr. Becky Winslow, preceptor for Manchester University School of Pharmacy.  Dr. Mary Weissman is a clinical pharmacogenomics specialist and inGENEious RX Incorporated consultant. Since earning her Doctor of Pharmacy degree from Arnold and Marie Schwartz College of Pharmacy and completing a two-year pharmacogenomics fellowship in a clinical laboratory's medical affairs department, Dr. Weissman has applied her pharmacogenomics expertise in clinical diagnostic laboratories. At those laboratories, she has scientifically, and clinically supported pharmacogenomics stakeholders to increase clinical pharmacogenomics implementation into clinical settings. Holding titles such as clinical scientist, she has authored and developed medical content to educate healthcare providers and patients about pharmacogenomics and authored clinical decision support tools prescribers use to leverage pharmacogenomic insights in medication therapy management. Through educational trainings, white papers, presentations, and webinars, she has clarified pharmacogenomics' complexities and helped move pharmacogenomics toward a standard of care.  

Before founding inGENEious RX Incorporated, a boutique pharmacogenomics consulting firm, Dr. Winslow directed pharmacy business operations and clinical pharmacy programs in retail, hospital, long-term care, and public health pharmacies for Walmart Stores, Community Health Systems, Neil Medical Group, and the North Carolina Department of Health and Human Services. Since founding inGENEious RX over eleven years ago, Dr. Winslow has worked with numerous distinguished vendors in the pharmacogenomics industry including Translational Software, Admera Health, Genemarkers, National Association of Chain Drug Stores, Kentucky Teachers' Retirement System, GenXys, and Thermo Fisher Scientific.  A sought-after pharmacogenomics subject matter expert, Dr. Winslow, has authored PGx payer databases and billing and coding algorithms and served Mintz Law as the expert medical necessity reviewer of Medicare PGx claims. She is an authority in pharmacogenomics access and reimbursement and specializes in business strategy consulting for pharmacogenomics stakeholders.   Dr. Winslow is an Advanced Pharmacy Practice Experience preceptor for Manchester University School of Pharmacy PharmD/Masters in PGx students and a registered trainer for the University of Pittsburgh's Test2Learn (TM) Community PGx Certificate Program. Dr. Winslow is a member of the Clinical Pharmacogenetics Implementation Consortium, the NCPDP PGx Task Force, and the Get the Medications Right Institute.  In 2021, Welp Magazine recognized Dr. Winslow's podcast, the PGx for Pharmacists Podcast, as the world's ninth most listened-to genetics podcast. Her podcast shares the top 20 most listened-to genomics podcast list with genomics podcasts created by such notable podcasters as the National Cancer Institute and the American Heart Association. The Pharmacy Podcast Network recognized Dr. Winslow in 2021 as a Top 50 pharmacy influencer. Entities frequently recruit Dr. Winslow to present PGx topics. She has presented at conferences for the National Association of Boards of Pharmacy, the National Association of Specialty Pharmacy, the Inovalon Customer Congress, and the Association for Molecular Pathology and on the Labroots' and Precision Medicine Institute's platforms.  Dr. Winslow earned her Bachelor of Science in Biology and Doctor of Clinical Pharmacy degrees from Campbell University. Lexi Wensel is a 2024 Manchester University School of Pharmacy graduate where she earned her Doctorate in Pharmacy and Masters in Pharmacogenomics. When this episode was recorded in April 2024, Lexi was completing an advanced pharmacy practice experience with Dr. Becky Winslow, preceptor for Manchester University School of Pharmacy. While studying to become a pharmacist, Lexi gained practical clinical pharmacy experience while working as a pharmacy intern at both Meijer pharmacy and Marion Health Hospital.   Beyond her academic and professional endeavors, Lexi is deeply committed to giving back to the community. She serves as a board member for an organization called Guatemala Family Development where she contributed to initiatives aimed at improving healthcare access and promoting wellness in underserved communities. At the time this episode was recorded, Lexi was completing an advanced pharmacy practice experience with Dr. Becky Winslow, preceptor for Manchester University School of Pharmacy.  Dr. Mary Weissman is a clinical pharmacogenomics specialist and inGENEious RX Incorporated consultant. Since earning her Doctor of Pharmacy degree from Arnold and Marie Schwartz College of Pharmacy and completing a two-year pharmacogenomics fellowship in a clinical laboratory's medical affairs department, Dr. Weissman has applied her pharmacogenomics expertise in clinical diagnostic laboratories. At those laboratories, she has scientifically, and clinically supported pharmacogenomics stakeholders to increase clinical pharmacogenomics implementation into clinical settings. Holding titles such as clinical scientist, she has authored and developed medical content to educate healthcare providers and patients about pharmacogenomics and authored clinical decision support tools prescribers use to leverage pharmacogenomic insights in medication therapy management. Through educational trainings, white papers, presentations, and webinars, she has clarified pharmacogenomics' complexities and helped move pharmacogenomics toward a standard of care.  

Tune in to the latest episode of Diabetes Day by Day! This time, Drs. Neil Skolnik and Sara Wettergreen zero in on nutrition in diabetes, offering practical tips and advice to help you thrive. Our special guests, Stacey Krawczyk, MS, RD, Director of Nutrition, and Toby Smithson, MS, RDN, CDCES, FAND, Senior Manager of Nutrition and Wellness—both from the American Diabetes Association®—share their insights and personal stories. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Stacey Krawczyk, MS, RD, Director of Nutrition at the American Diabetes Association® Toby Smithson, MS, RDN, CDCES, FAND, Senior Manager of Nutrition and Wellness at the American Diabetes Association® For additional resources, be sure to check out: The American Diabetes Association®'s Nutrition Tips The American Diabetes Association®'s Eating Patterns Healthy Plates Around the World Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

IN THIS EPISODE...Today's guest is Dr. Paul Peak, PharmD, the VP of Clinical Pharmacy at Sedgwick. With over a decade of expertise and nine years of prior pharmacy experience, Paul oversees Pharmacy Benefit Management partnerships and leads a clinical pharmacist team.In a dynamic landscape of pharmacy care, Dr. Paul Peak champions innovative strategies to manage employee wellness in workers' compensation. By aligning team vision with organizational goals and fostering a culture of open idea-sharing, he cultivates a collaborative environment that enhances professional growth while promoting a healthy work-life balance!------------Full show notes, guest bio, links to resources mentioned, and other compelling episodes can be found at http://LeadYourGamePodcast.com. (Click the magnifying icon at the top right and type “Dr. Paul”)Love the show? Subscribe, rate, review, and share! Learn more about us! https://shockinglydifferent.com/-------------WHAT TO LISTEN FOR:1. What are the current trends in pharmacy that impact the industry?2. How can teams align their vision with company goals effectively?3. How can organizations foster a culture of idea-sharing among teams?4. What key conversations are currently taking place in healthcare?5. How can individuals balance work and personal life in today's environment?6. What strategies can enhance leadership and team dynamics?7. How can leaders encourage open dialogue about personal and professional challenges?------------FEATURED TIMESTAMPS:[02:56] Paul's Personal Life[04:23] Paul and his team's Role at Sedgwick[08:56] Current Trends in Pharmacy[13:43] How to Align Team Vision with Company Goals[15:18] Signature Segment: Paul's entry into the LATTOYG Playbook: Leadership Approach and Team Dynamics[20:24] Strategies for Fostering Idea Sharing in Teams[22:07] Key Conversations in Healthcare[26:56] Balancing Work and Personal Life[29:58] Signature Segment: Paul's LATTOYG Tactic of Choice: Leading with Executive Presence[32:38] Connect with Paul------------ADDITIONAL RESOURCES FOR YOU:Overview: Our Signature Leadership Development Experience: http://bit.ly/DevelopYourGame

In this podcast, Dr. Leah Webster and Dr. Corey Wachter discuss the AJHP Descriptive Report, “The vital role of clinical pharmacy services within the hospital at home interdisciplinary team,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

New treatments and managing side effects are key challenges in kidney cancer care. In our latest episode of The PQI Podcast, we team up with the Kidney Cancer Association, Emily Wang, PharmD, BCOP, from MD Anderson, and Julia Stevens, PharmD, BCOP, from Beth Israel Deaconess, to share valuable insights into the newest advancements in kidney cancer therapies and practical strategies for managing side effects from TKI and IO treatments. Listen now to gain valuable knowledge that can transform your patient care approach.Learn more about the Kidney Cancer Association here.